Transparency Market
Research has published a report on the U.S. vaccine market for the
2014-2020 period. According to the report, this market will expand at
a CAGR of 4.3% between 2014 and 2020. This report on the U.S. vaccine
market presents an insightful and in-depth overview of the current
and future growth potential of the human and animal vaccine markets.
The title of this report is “U.S. Vaccine Market - Industry
Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020” and
is available for sale on the company’s website.
Request for
Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=553
A vaccine is a
biological preparation that delivers active acquired immunity against
a particular disease. It is administered either through needle
injections, orally, or by aerosol. Vaccination involves the
administration of a killed or weakened organism into the body that
develops immunity in the body against that organism. Vaccines cause
immunization; there are also some diseases that provide immunization
after recovery from the disease.
According to the
Centers for Disease Control and Prevention (CDC), vaccination
programs across the U.S. have been successful in the eradication of
lethal diseases such as polio, smallpox, and diphtheria, while
diseases such as tetanus, rubella, and measles have been largely
controlled. Vaccination administered as a preventive measure has
helped save the lives of millions of individuals in the U.S.
In the U.S., strict
regulations imposed by the federal government, which mandate
immunization against certain diseases is driving the U.S. vaccines
market. Meanwhile, the rising incidence of zoonotic diseases among
animals and the high risk of transmitting its associated infection to
humans is propelling the growth of the animal vaccines market.
Moreover, widespread pet ownership in the country has significantly
contributed to the growth of the animal vaccines market in the U.S.
Factors such as the rising consumption of poultry and meat products
and recent approvals of Prime Pac PRRS+ and Once PMH IN have also
bolstered the growth of the U.S. animal vaccine market.
Request a
Brochure of the Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=553
On the flip side,
the stringent regulatory framework that governs the approval process
of vaccines in the U.S. impedes the growth of this market to a
certain extent. Moreover, the high cost involved in the research and
development of new vaccines will also hamper the growth of this
market during the forecast period.
The report segments
the U.S. vaccine market into human vaccines and animal vaccine to
analyze this market during the forecast period. By vaccine type, the
U.S. human vaccine market is divided into adult and pediatric
vaccines. By antigen, this market is divided into hepatitis,
meningococcal, human papillomavirus (HPV), influenza, pneumococcal,
combination vaccines, and others.
The U.S. market for
animal vaccines is segmented into companion animal and livestock
vaccines. The companion animal vaccines segment is further
sub-segmented into canine and feline. In 2013, canine vaccines held a
slightly larger share than feline vaccines due to the higher average
cost of canine vaccines.
Enquiry for
discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=553
Some of the leading
players in the U.S. vaccines market are Novartis International AG,
Merck & Co. Inc., Sanofi, GlaxoSmithKline plc, and Merck &
Co.
About Us
Transparency Market
Research is a next-generation market intelligence provider, offering
fact-based solutions to business leaders, consultants, and strategy
professionals.
Our reports are
single-point solutions for businesses to grow, evolve, and mature.
Our real-time data collection methods along with ability to track
more than one million high growth niche products are aligned with
your aims. The detailed and proprietary statistical models used by
our analysts offer insights for making right decision in the shortest
span of time. For organizations that require specific but
comprehensive information we offer customized solutions through adhoc
reports. These requests are delivered with the perfect combination of
right sense of fact-oriented problem solving methodologies and
leveraging existing data repositories.
TMR believes that
unison of solutions for clients-specific problems with right
methodology of research is the key to help enterprises reach right
decision.
US Office
Contact
90 State Street,
Suite 700
Albany, NY 12207
Tel:
+1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment